NV
Nest.Bio Ventures
Venture CapitalActiveNest.Bio Ventures takes a deep science, cross-border approach to translating breakthrough science into revolutionary companies.
11
Investments
2
Exits
$100M
AUM
18.2%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Nest.Bio Ventures.
Investment Thesis & Strategy
Nest.Bio Ventures invests in various stages of biotech, healthcare, and life science companies with a focus on translating breakthrough science into revolutionary companies. They take a cross-border approach to their investments.
Investment Activity
Deals per year over the last 3 years
5
20212
20225
2023Portfolio Companies
Selected investments from their portfolio of 11 companies
V
VedaBio
Biotech · Series A, 2023
R
Rondo Therapeutics
Biotech · Series A, 2023
R
Rondo Therapeutics
Biotech · Series A, 2023
V
VedaBio
Biotech · Series A, 2023
R
RavelBio
Biotech · Series A, 2023
R
Rgenta Therapeutics
Biotech · Series A, 2022
R
Rgenta Therapeutics
Biotech · Series A, 2022
A
Aitia
Biotech · Series A, 2021
S
Seismic Therapeutics
Biotech · Series A, 2021
E
Enliven Therapeutics
Biotech · Series A, 2021
T
Tessera Therapeutics
Biotech · Series B, 2021
D
DeepCure
Biotech · Series A, 2021
Notable Exits
CompanyTypeYearValue / Acquirer
Sana BiotechnologyIPO2021$7.1B
Lyell ImmunopharmaIPO2021$1.6B
Frequently Asked Questions
Nest.Bio Ventures focuses on Series A, Series B, Series C+ stage investments.